From: A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables
N | Number of infection cases | Number of disease cases | Vaccine efficiency(95% CI) on disease | |||
---|---|---|---|---|---|---|
Vaccine | Placebo | Vaccine | Placebo | |||
1 | 2954 | 2 | 213 | 0 | 23 | 100.0%(82.5%,100.0%) |
2 | 3200 | 10 | 86 | 1 | 6 | 83.3%(-37.6%,99.6%) |
3 | 529 | 2 | 45 | 0 | 2 | 100.0%(-431.4%,100%) |
4 | 3674 | 27 | 130 | 3 | 8 | 62.7%(-55.5%,93.6%) |
5 | 3452 | 24 | 296 | 0 | 30 | 100.0%(87.1%,100.0%) |